OSU-2S


CAS No. : 1351056-65-9

1351056-65-9
Price and Availability of CAS No. : 1351056-65-9
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-117720
M.Wt: 335.52
Formula: C21H37NO2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1351056-65-9 :

OSU-2S is a potent PKCδ activator. OSU-2S inhibits cell proliferation and migration. OSU-2S decreases the expression of p-ERK1/2, increases the expression of PKCδ (38 kDa) when combined with Sorafenib (HY-10201). OSU-2S induces Apoptosis. OSU-2S slao is a non-immunosuppressive analogue of FTY720. OSU-2S shows anticancer activity[1][2]. In Vitro:OSU-2S (1.25, 2.5 µM; 48 h) decreases the expression of p-ERK1/2, increases the expression of PKCδ (38 kDa) when combined with Sorafenib (HY-10201) (2.5, 5 µM)[1].
OSU-2S/Sorafenib (1.25, 2.5 µM; 8 h) combinantion inhibits cell proliferative and migration[1].
OSU-2S (0, 1, 2.5, 5 µM; 0-24 h) decreases the expression of PARP in a dose and time-dependent manner in Hep3B cells[2].
OSU-2S (5 µM; 12, 24 h) induces apoptosis in Hep3B cells[2].
OSU-2S (0-10 µM; 1 h) stimulates ROS production in a dose-dependent manner in Hep3B, Huh7, PLC-5 cells[2]. In Vivo:OSU-2S (5, 10 mg/kg; i.p.; once daily for 42 days) suppresses the tumor growth in mouse[2].

Your information is safe with us.